Gait Disorders, Neurologic
Recent clinical, regulatory, research and industry developments relating to this disease.
Freezing of gait in Parkinson's disease: pathophysiology, risk factors and treatments.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 2 clinical trials with recent milestones (1 completed or reporting results).
Clinical MilestonesViewHide
- 2026-01-30ClinicalLocomotor Training With Testosterone to Promote Bone and Muscle HealthPrimary completion
- 2025-10-01ClinicalCombination Effect of Proprioceptive Training and Transcranial Magnetic Stimulation on Selected Gait Kinematic Parameters in Stroke PatientsCompleted
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Leading journals1
- Translational neurodegeneration1
Leading researchers4
- Chen S1
- Gao C1
- Liu J1
- Tan Y1
Affiliations (unnormalised)2
- 2Co-innovation Center of Neuroregeneration1
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine1
Reference
Authoritative identity, definition & identifiers.
Gait abnormalities that are a manifestation of nervous system dysfunction. These conditions may be caused by a wide variety of disorders which affect motor control, sensory feedback, and muscle strength including: CENTRAL NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or MUSCULAR DISEASES.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.